XWELL, Inc. (XWEL)
NASDAQ: XWEL · Real-Time Price · USD
1.050
-0.140 (-11.76%)
Mar 28, 2025, 4:00 PM EDT - Market closed
XWELL Revenue
XWELL had revenue of $8.42M in the quarter ending September 30, 2024, with 12.77% growth. This brings the company's revenue in the last twelve months to $33.83M, up 11.79% year-over-year. In the year 2023, XWELL had annual revenue of $30.11M, down -46.18%.
Revenue (ttm)
$33.83M
Revenue Growth
+11.79%
P/S Ratio
0.13
Revenue / Employee
$100,395
Employees
337
Market Cap
5.52M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 30.11M | -25.83M | -46.18% |
| Dec 31, 2022 | 55.94M | -17.79M | -24.13% |
| Dec 31, 2021 | 73.73M | 65.34M | 779.30% |
| Dec 31, 2020 | 8.39M | -38.92M | -82.28% |
| Dec 31, 2019 | 47.31M | -2.34M | -4.70% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 400.28B |
| Johnson & Johnson | 88.82B |
| Merck & Co. | 64.17B |
| AbbVie | 56.33B |
| AstraZeneca | 54.07B |
| Novartis AG | 51.72B |
| Eli Lilly and Company | 45.04B |
| Thermo Fisher Scientific | 42.88B |
XWEL News
- 17 days ago - XWELL Announces Plan for Strategic Investment in Medical Spas to Advance Wellness and Beauty Offerings - GlobeNewsWire
- 2 months ago - XWELL Announces Closing of $4 Million Private Placement Consisting of Convertible Preferred Stock and Warrants - GlobeNewsWire
- 2 months ago - XWELL Announces Senior Leadership Appointments and Changes - GlobeNewsWire
- 4 months ago - Open Letter to XWELL Shareholders from CEO Ezra Ernst - GlobeNewsWire
- 4 months ago - XWELL, Inc. (XWEL) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - XWELL, Inc. Reports Third Quarter 2024 Results - GlobeNewsWire
- 4 months ago - XWELL, Inc. to Report Third Quarter 2024 Results on Thursday, November 14, 2024 - GlobeNewsWire
- 6 months ago - ThredUp And 2 Other Stocks Under $2 Executives Are Buying - Benzinga